Sensus Ev To Free Cash Flow vs Begin Period Cash Flow Analysis

SRTS Stock

USD 8.51 0.09 1.05%

Sensus Healthcare financial indicator trend analysis is much more than just breaking down Sensus Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sensus Healthcare is a good investment. Please check the relationship between Sensus Healthcare Ev To Free Cash Flow and its Begin Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensus Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Sensus Stock please use our How to Invest in Sensus Healthcare guide.

Ev To Free Cash Flow vs Begin Period Cash Flow

Ev To Free Cash Flow vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sensus Healthcare Ev To Free Cash Flow account and Begin Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Sensus Healthcare's Ev To Free Cash Flow and Begin Period Cash Flow is -0.08. Overlapping area represents the amount of variation of Ev To Free Cash Flow that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Sensus Healthcare, assuming nothing else is changed. The correlation between historical values of Sensus Healthcare's Ev To Free Cash Flow and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Free Cash Flow of Sensus Healthcare are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Ev To Free Cash Flow i.e., Sensus Healthcare's Ev To Free Cash Flow and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.08

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Sensus Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sensus Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensus Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Sensus Stock please use our How to Invest in Sensus Healthcare guide.Selling General Administrative is likely to drop to about 3.9 M in 2024. Tax Provision is likely to drop to about 142.5 K in 2024

	2021	2022	2023	2024 (projected)
Gross Profit	17.0M	29.6M	14.1M	14.1M
Total Revenue	27.0M	44.5M	24.4M	22.1M

Gross Profit Total Revenue

Sensus Healthcare fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Common Stock Shares Outstanding		0.91	0.35	0.09	0.81	0.88	0.54	0.82	0.8	-0.33	-0.81	0.01	0.82	0.83	0.7	0.42	0.18	0.91	0.86	0.94	0.71	0.57	0.86	0.98	0.87	0.76
Total Assets	0.91		0.28	0.18	0.74	1.0	0.4	0.9	0.65	-0.54	-0.89	0.34	0.79	0.93	0.81	0.49	-0.13	0.99	0.91	0.88	0.6	0.62	0.85	0.9	0.78	0.71
Short Long Term Debt Total	0.35	0.28		0.42	0.51	0.24	0.31	0.17	0.33	-0.43	-0.08	-0.19	0.53	0.15	0.29	-0.07	0.14	0.37	0.26	0.58	0.31	0.02	0.06	0.36	0.5	0.17
Other Current Liab	0.09	0.18	0.42		0.2	0.18	0.25	0.11	-0.07	-0.43	-0.06	-0.11	0.41	0.04	-0.05	-0.11	-0.06	0.2	0.32	0.32	-0.02	-0.11	-0.01	0.25	0.15	-0.1
Total Current Liabilities	0.81	0.74	0.51	0.2		0.68	0.47	0.62	0.54	-0.53	-0.63	0.0	0.96	0.67	0.35	0.12	0.11	0.76	0.85	0.79	0.55	0.26	0.66	0.78	0.96	0.42
Total Stockholder Equity	0.88	1.0	0.24	0.18	0.68		0.35	0.91	0.61	-0.54	-0.9	0.38	0.74	0.94	0.82	0.52	-0.17	0.98	0.89	0.85	0.55	0.65	0.85	0.87	0.71	0.71
Other Liab	0.54	0.4	0.31	0.25	0.47	0.35		0.24	0.79	0.13	-0.09	-0.45	0.55	0.14	0.35	-0.04	0.66	0.35	0.55	0.5	0.88	0.06	0.18	0.61	0.65	0.46
Net Tangible Assets	0.82	0.9	0.17	0.11	0.62	0.91	0.24		0.55	-0.57	-0.94	0.55	0.67	0.85	0.77	0.77	-0.32	0.9	0.79	0.77	0.49	0.86	0.75	0.8	0.65	0.84
Property Plant And Equipment Net	0.8	0.65	0.33	-0.07	0.54	0.61	0.79	0.55		0.1	-0.47	-0.21	0.56	0.51	0.72	0.26	0.44	0.64	0.58	0.69	0.97	0.44	0.55	0.8	0.73	0.79
Current Deferred Revenue	-0.33	-0.54	-0.43	-0.43	-0.53	-0.54	0.13	-0.57	0.1		0.53	-0.57	-0.58	-0.5	-0.29	-0.41	0.63	-0.56	-0.51	-0.47	0.09	-0.41	-0.26	-0.31	-0.39	-0.21
Net Debt	-0.81	-0.89	-0.08	-0.06	-0.63	-0.9	-0.09	-0.94	-0.47	0.53		-0.51	-0.64	-0.95	-0.68	-0.65	0.38	-0.9	-0.75	-0.74	-0.37	-0.77	-0.87	-0.77	-0.62	-0.71
Retained Earnings	0.01	0.34	-0.19	-0.11	0.0	0.38	-0.45	0.55	-0.21	-0.57	-0.51		0.01	0.39	0.39	0.63	-0.87	0.32	0.17	0.0	-0.2	0.6	0.18	-0.05	-0.06	0.29
Accounts Payable	0.82	0.79	0.53	0.41	0.96	0.74	0.55	0.67	0.56	-0.58	-0.64	0.01		0.66	0.41	0.15	0.09	0.8	0.92	0.84	0.58	0.28	0.66	0.83	0.94	0.45
Cash	0.83	0.93	0.15	0.04	0.67	0.94	0.14	0.85	0.51	-0.5	-0.95	0.39	0.66		0.72	0.48	-0.28	0.94	0.78	0.77	0.41	0.62	0.91	0.8	0.66	0.62
Non Current Assets Total	0.7	0.81	0.29	-0.05	0.35	0.82	0.35	0.77	0.72	-0.29	-0.68	0.39	0.41	0.72		0.58	-0.13	0.8	0.55	0.68	0.65	0.72	0.59	0.67	0.48	0.82
Non Currrent Assets Other	0.42	0.49	-0.07	-0.11	0.12	0.52	-0.04	0.77	0.26	-0.41	-0.65	0.63	0.15	0.48	0.58		-0.46	0.47	0.29	0.38	0.17	0.97	0.29	0.38	0.15	0.8
Other Assets	0.18	-0.13	0.14	-0.06	0.11	-0.17	0.66	-0.32	0.44	0.63	0.38	-0.87	0.09	-0.28	-0.13	-0.46		-0.14	0.05	0.14	0.48	-0.41	-0.04	0.22	0.24	-0.03
Cash And Short Term Investments	0.91	0.99	0.37	0.2	0.76	0.98	0.35	0.9	0.64	-0.56	-0.9	0.32	0.8	0.94	0.8	0.47	-0.14		0.88	0.91	0.57	0.62	0.86	0.89	0.78	0.7
Net Receivables	0.86	0.91	0.26	0.32	0.85	0.89	0.55	0.79	0.58	-0.51	-0.75	0.17	0.92	0.78	0.55	0.29	0.05	0.88		0.82	0.61	0.4	0.77	0.88	0.87	0.55
Common Stock Total Equity	0.94	0.88	0.58	0.32	0.79	0.85	0.5	0.77	0.69	-0.47	-0.74	0.0	0.84	0.77	0.68	0.38	0.14	0.91	0.82		0.61	0.52	0.74	0.95	0.82	0.67
Non Current Liabilities Total	0.71	0.6	0.31	-0.02	0.55	0.55	0.88	0.49	0.97	0.09	-0.37	-0.2	0.58	0.41	0.65	0.17	0.48	0.57	0.61	0.61		0.34	0.43	0.73	0.75	0.71
Inventory	0.57	0.62	0.02	-0.11	0.26	0.65	0.06	0.86	0.44	-0.41	-0.77	0.6	0.28	0.62	0.72	0.97	-0.41	0.62	0.4	0.52	0.34		0.46	0.53	0.31	0.89
Other Current Assets	0.86	0.85	0.06	-0.01	0.66	0.85	0.18	0.75	0.55	-0.26	-0.87	0.18	0.66	0.91	0.59	0.29	-0.04	0.86	0.77	0.74	0.43	0.46		0.82	0.66	0.53
Other Stockholder Equity	0.98	0.9	0.36	0.25	0.78	0.87	0.61	0.8	0.8	-0.31	-0.77	-0.05	0.83	0.8	0.67	0.38	0.22	0.89	0.88	0.95	0.73	0.53	0.82		0.85	0.74
Total Liab	0.87	0.78	0.5	0.15	0.96	0.71	0.65	0.65	0.73	-0.39	-0.62	-0.06	0.94	0.66	0.48	0.15	0.24	0.78	0.87	0.82	0.75	0.31	0.66	0.85		0.56
Property Plant And Equipment Gross	0.76	0.71	0.17	-0.1	0.42	0.71	0.46	0.84	0.79	-0.21	-0.71	0.29	0.45	0.62	0.82	0.8	-0.03	0.7	0.55	0.67	0.71	0.89	0.53	0.74	0.56

Click cells to compare fundamentals

Sensus Healthcare Account Relationship Matchups

Sensus Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	16.2M	16.4M	16.5M	16.6M	16.3M	15.2M
Total Assets	36.9M	28.0M	32.2M	56.7M	53.7M	32.5M
Other Current Liab	187.5K	(418.9K)	508K	403K	351K	333.5K
Total Current Liabilities	6.5M	4.9M	6.0M	7.7M	4.2M	5.8M
Total Stockholder Equity	28.0M	21.5M	26.0M	48.1M	48.8M	25.9M
Other Liab	1.3M	579.3K	262K	139K	159.9K	151.9K
Net Tangible Assets	27.7M	21.2M	25.9M	48.0M	55.2M	58.0M
Property Plant And Equipment Net	2.5M	2.4M	774K	1.2M	1.2M	1.2M
Current Deferred Revenue	1.2M	1.5M	1.2M	693K	657K	765.9K
Net Debt	(6.7M)	(13.5M)	(14.3M)	(24.5M)	(22.4M)	(21.2M)
Retained Earnings	(15.2M)	(22.1M)	(17.9M)	6.3M	6.8M	7.1M
Accounts Payable	4.8M	2.9M	4.1M	5.5M	2.8M	3.9M
Cash	8.1M	14.9M	14.5M	25.5M	23.1M	13.6M
Non Current Assets Total	2.9M	2.8M	995K	3.0M	4.2M	2.3M
Non Currrent Assets Other	101.6K	69.4K	75K	24K	804K	844.2K
Other Assets	101.6K	69.4K	75K	(17.0K)	(19.5K)	(18.6K)
Cash And Short Term Investments	15.5M	14.9M	14.5M	25.5M	23.1M	15.5M
Net Receivables	14.0M	3.8M	12.1M	17.3M	10.6M	9.0M
Common Stock Total Equity	165.4K	165.6K	167K	169K	194.4K	134.4K
Liabilities And Stockholders Equity	36.9M	28.0M	32.2M	56.7M	53.7M	32.5M
Non Current Liabilities Total	2.5M	1.7M	262K	969K	656K	764.8K
Inventory	3.0M	4.4M	1.8M	3.5M	11.9M	12.5M
Other Current Assets	1.5M	4.1M	5.4M	6.9M	3.9M	2.8M
Other Stockholder Equity	43.1M	43.4M	43.8M	41.6M	41.9M	36.0M
Total Liab	8.9M	6.5M	6.2M	8.7M	4.9M	6.5M
Property Plant And Equipment Gross	2.5M	2.4M	774K	1.2M	3.1M	3.3M
Total Current Assets	34.0M	25.2M	31.2M	53.7M	49.5M	30.2M
Short Term Debt	309.5K	606.4K	225K	190K	374K	392.7K
Intangible Assets	337.4K	337.9K	146K	50K	45K	42.8K
Common Stock	165.4K	165.6K	167K	169K	194.4K	139.6K
Property Plant Equipment	2.5M	1.4M	774K	243K	279.5K	265.5K
Capital Surpluse	43.3M	43.7M	44.1M	45.0M	51.8M	37.9M
Deferred Long Term Liab	1.3M	579.3K	262K	139K	159.9K	151.9K
Retained Earnings Total Equity	(15.2M)	(22.1M)	(17.9M)	6.3M	7.2M	7.6M
Treasury Stock	(252.6K)	(309.9K)	(325K)	(3.4M)	(3.1M)	(2.9M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sensus Stock Analysis

When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC